Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Gynecologic Malignancies: A Single Institution Experience

被引：0
|
作者：
Cuttino, L. W. [1 ]
Evans, J. E. [1 ]
Snyder, W. J. [1 ]
Ford, T. C. [1 ]
Egloff, S. Arnold [2 ]
Boardman, C. H. [1 ]
机构：
[1] Henrico Doctors Hosp, Sarah Cannon Canc Inst, Richmond, VA USA
[2] Sarah Cannon Canc Inst, Nashville, TN USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2594
引用
下载
收藏
页码：E266 / E266
页数：1
相关论文
共 50 条
  • [31] Stereotactic Ablative Radiotherapy (SABR) for Pulmonary Oligometastases and Oligoprogression
    Helou, Joelle
    Thibault, Isabelle
    Yeung, Latifa L.
    Poon, Ian
    Tjong, Michael
    Chiang, Andrew
    Jain, Suneil
    Soliman, Hany
    Cheung, Patrick
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S636 - S636
  • [32] Stereotactic ablative radiotherapy (SABR) for lung oligometastases can prevent or delay need for systemic anti-cancer treatment (SACT): single institution experience
    Lynch, Sophie
    Ahmad, Shahreen
    Taylor, Benjamin
    Skwarski, Michael
    Smith, Daniel
    LUNG CANCER, 2023, 178 : S56 - S57
  • [33] Stereotactic Ablative Radiotherapy for non-spinal bone metastasis. A single institution experience
    Acosta Rojas, A.
    Nunez, M.
    Montero-Luis, A.
    Sanchez-Saugar, E.
    Hernando-Requejo, O.
    Ciervide-Jurio, R.
    Lopez-Gonzalez, M.
    Garcia-Aranda, M.
    Valero-Albarran, J.
    Rubio-Rodriguez, M. C.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S877 - S878
  • [34] Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial
    Senan, S.
    Olson, R.
    Harrow, S.
    Gaede, S.
    Louie, A.
    Haasbeek, C.
    Mulroy, L.
    Lock, M.
    Rodrigues, G.
    Yaremko, B.
    Schellenberg, D.
    Ahmad, B.
    Griffioen, G.
    Senthi, S.
    Liu, M.
    Moore, K.
    Currie, S.
    Bauman, G.
    Warner, A.
    Palma, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes
    Bates, James E.
    De Leo, Alexandra N.
    Morris, Christopher G.
    Amdur, Robert J.
    Dagan, Roi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (07): : 2309 - 2314
  • [36] Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
    Donovan, Elysia K.
    Lo, Simon S.
    Beriwal, Sushil
    Chen, Hanbo
    Cheung, Patrick
    Keller, Andrew
    Nwachukwu, Chika
    Mantz, Constantine
    Pond, Gregory R.
    Schnarr, Kara
    Swaminath, Anand
    Albuquerque, Kevin
    Leung, Eric
    JAMA ONCOLOGY, 2024, 10 (07) : 941 - 948
  • [37] Stereotactic ablative radiotherapy for oligometastatic disease: why and how?
    Widder, J.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S246 - S247
  • [38] Neoadjuvant Stereotactic Ablative and Hypofractionated Radiotherapy for Oligometastatic NSCLC
    Newman, N. B.
    Anderson, J. L.
    Shinohara, E. T.
    Michael, P.
    Attia, A.
    Osmundson, E. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1196 - 1196
  • [39] Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience
    Armstrong, S.
    Makris, A.
    Belessiotis-Richards, K.
    Abdul-Latif, M.
    Ostler, P.
    Shah, N.
    Miles, D.
    Tsang, Y. M.
    CLINICAL ONCOLOGY, 2024, 36 (06) : 362 - 369
  • [40] Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease
    Broomfield, J. A.
    Greenspoon, J. N.
    Swaminath, A.
    CURRENT ONCOLOGY, 2014, 21 (03) : 115 - 117
12345